Actively Recruiting
A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia
Led by Jiangsu HengRui Medicine Co., Ltd. · Updated on 2026-04-30
150
Participants Needed
7
Research Sites
163 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study is being conducted to evaluate the efficacy, and safety of of Hetrombopag Olamine Tablets Vs Placebo in Patients with Chemotherapy-Induced Thrombocytopenia.
CONDITIONS
Official Title
A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 18 years or older at screening
- Histologically or cytologically confirmed solid tumor (e.g., non-small-cell lung carcinoma, breast, ovarian, bladder, pancreatic, gastrointestinal, or colon/colorectal cancer)
- Receiving platinum- and/or gemcitabine-containing chemotherapy regimens on 21-day cycles
- Eastern Cooperative Oncology Group performance status of 0 to 2
- Life expectancy of at least 6 months
- Signed informed consent form and good compliance
You will not qualify if you...
- Hematopoietic diseases other than chemotherapy-induced thrombocytopenia
- Hematologic malignancies
- Thrombocytopenia caused by reasons other than chemotherapy within 6 months prior to Study Day 1
- Untreated brain metastases or leptomeningeal metastasis
- Conditions requiring emergency treatment (e.g., superior vena cava syndrome, spinal cord compression)
- Severe cardiovascular disorders or interventions within 6 months
- Arterial or venous thrombosis within 6 months
- Known bleeding disorders or platelet dysfunction
- Severe hemorrhage during screening
- Acute or uncontrolled hepatitis B or C infection
- Human immunodeficiency virus (HIV) infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Cancer and Blood Specialty Clinic
Los Alamitos, California, United States, 90254
Not Yet Recruiting
2
AdventHealth Hematology and Oncology Denver Cypress Hematology and Oncology
Denver, Colorado, United States, 80210
Not Yet Recruiting
3
Oncology & Hematology Associates of West Broward
Coral Springs, Florida, United States, 33065
Not Yet Recruiting
4
Mid-Florida Hematology & Oncology Centers, P.A.
Orange City, Florida, United States, 32763
Actively Recruiting
5
Springfield Clinic
Springfield, Illinois, United States, 62702
Not Yet Recruiting
6
Morristown Medical Center
Morristown, New Jersey, United States, 07039
Not Yet Recruiting
7
New York Cancer and Blood Specialists One Oncology
Shirley, New York, United States, 11967
Not Yet Recruiting
Research Team
J
Junye Xiong
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here